2[1]Amos AF, McCarty PJ, Zimmet P. The rising global burden of diabetes and its complications. Estimates and projections to the year 2010,Diab Med,1997,7:85. 被引量：1
3[4]Diabetes Drafting Group. Prevalence of small vessel and large vessel disease in diabetic patients from 14 centers:The world health organization multinational study of vascular disease in diabetics. Diabetologia. 1985,28:615～640. 被引量：1
4Angles-Cano E, de-la-Pena-Diaz A, et al. Inhibition of fibrinolysis by lipoprotein(a). Ann N Y Acad Sci,2001,936.. 261-275. 被引量：1
5Brousseau ME, Schaefer EJ. New developments in the prevention of atherosclerosis in patients with low-high density lipoprotein cholesterol. Curr Atheroscler Rep, 2001,3 : 365-372. 被引量：1
6Parving HH, Oxenboll B, Svendsen PA, et al. Early detection of patients at risk of developing diabetic nephropathy: A longitudinal study of urinary albumin excretion. Acta Endocrinol (Copenh), 1982,100:550-555. 被引量：1
7Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine:a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med, 1999,130:461-470. 被引量：1
8Madan R, Gupt B, Saluja S,et al. Coagulation profile in diabetes and its association with diabetic microvascular complications. J Assoc Physicians India, 2010,58:481-484. 被引量：1
10Klein RL, Hunter SJ, Jenkins AJ, et al. Fibrinogen is a marker for nephropathy and peripheral vascular disease in type 1 diabetes: studies of plasma fibrinogen and fibrinogen gene polymorphism in the DCCT/EDIC cohort. Diabetes Care, 2003,26,1439-1448. 被引量：1
6Shah B,Sha D,Xie D et al.The relationship between diabetes,metabolic syndrome,and platelet activity as measured by mean platelet volume: the National Health And Nutrition Examination Survey,1999-2004[J].Diabetes Care,2012,35(5):1074-1078. 被引量：1
7Lee KM,Lee HJ,Kim MK,et al.Cilostazol inhibits high glucose- and angiotensin II-induced type 1 plasminogen activator inhibitor expression in artery wall and neointimal region after vascular injury[J].Atherosclerosis,2009,207(2):391-398. 被引量：1
8Ertugrul DT,Tutal E,Yildiz M,et al.Aspirin resistance is associated with glycemic control,the dose of aspirin,and obesity in type 2 diabetes mellitus[J].J Clin Endocrinol Metab,2010,95(6):2897-2901. 被引量：1
9Belch J,MacCuish A,Campbell I,et al.The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease[J].BMJ,2008,337:a1840.doi: 10.1136/bmj.a1840. 被引量：1
10Lipsky BA,Berend AR,Comia PB,et al, 2012 Infectious diseases society of america clinical practice guideline for the diagnosis and treatment of diabetic foot infectionsa [J]. Clinical Infectious Diseases, 2012,54(12) : 132-173. 被引量：1
